Safe and effective thrombolysis in free flap salvage: Intra-arterial urokinase infusion

• Published in: PloS one 2023-03, Vol.18 (3), p.e0282908-e0282908
• Main Authors: Kim, Jun Hyeok, Yoon, Sungyeon, Kwon, Heeyeon, Oh, Deuk Young, Jun, Young-Joon, Moon, Suk-Ho
• Format: Article
• Language: English
• Subjects: Anticoagulants; Biology and Life Sciences; Blood clots; Complications; Complications and side effects; Flaps (Surgery); Free Tissue Flaps - blood supply; Health risks; Hematemesis; Hematoma; Hemorrhage; Humans; Medical records; Medicine and Health Sciences; Microvasculature; Necrosis; Patient outcomes; Patients; Postoperative Complications - therapy; Reconstructive surgery; Retrospective Studies; Salvage Therapy - adverse effects; Stroke; Surgery; Thromboembolism; Thrombolysis; Thrombolytic drugs; Thrombolytic Therapy - methods; Thrombosis; Thrombosis - drug therapy; U-Plasminogen activator; Urokinase; Urokinase-Type Plasminogen Activator; Veins & arteries; Venous Thrombosis - complications; Venous Thrombosis - drug therapy
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0282908

Despite the high success rate in reconstruction using free tissue transfer, flap failure is often caused by microvascular thrombosis. In a small percentage of cases with complete flap loss, a salvage procedure is performed. In the present study, the effectiveness of intra-arterial urokinase infusion through the free flap tissue was investigated to develop a protocol to prevent thrombotic failure. The retrospective study evaluated the medical records of patients who underwent salvage procedure with intra-arterial urokinase infusion after reconstruction with free flap transfer between January 2013 and July 2019. Thrombolysis with urokinase infusion was administered as salvage treatment for patients who experienced flap compromise more than 24 hours after free flap surgery. Because of an external venous drainage through the resected vein, 100,000 IU of urokinase was infused into the arterial pedicle only into the flap circulation. A total of 16 patients was included in the present study. The mean time to re-exploration was 45.4 hours (range: 24-88 hours), and the mean quantity of infused urokinase was 69,688 IU (range: 30,000-100,000 IU). 5 cases presented with both arterial and venous thrombosis, while 10 cases had only venous thrombosis and 1 case had only arterial thrombosis; in a study of 16 patients undergoing flap surgery, 11 flaps were found to have survived completely, while 2 flaps experienced transient partial necrosis and 3 were lost despite salvage efforts. In other word, 81.3% (13 of 16) of flaps survived. Systemic complications, including gastrointestinal bleeding, hematemesis, and hemorrhagic stroke, were not observed. The free flap can be effectively and safely salvaged without systemic hemorrhagic complications using high-dose intra-arterial urokinase infusion within a short period of time without systemic circulation, even in delayed salvage cases. Urokinase infusion results in successful salvage and low rate of fat necrosis.